Established close industry-university-research cooperation relationship with Shanghai University and Suzhou Institute of Biomedical Engineering Technology, Chinese Academy of Sciences
01
Cooperation with Shanghai University
With the help of the school's professional advantages in automatic control and software engineering,
Focus on the research and development of high-end molecular diagnostic instruments such as automatic nucleic acid extraction and purification instrument, magnetic particle chemiluminescence immunoassay instrument, etc.
Chinese Academy of Sciences Suzhou Institute of Biomedical Engineering Technology
In cooperation with the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, the focus is on the development of rapid nucleic acid detection instruments for the new coronavirus.
The Anhui Provincial Department of Human Resources and Social Security approved the establishment of a provincial post-doctoral research station. Immuno-POCT production line-automatic chemiluminescence immunoassay analyzer was approved for marketing. Immune POCT production line - IL6, IL10, PCT, SAA, passed the registration test. The immune POCT production line-influenza virus immunochromatographic rapid detection kit was successfully developed. Molecular POCT production line-New coronavirus nucleic acid RPA rapid detection kit was successfully developed. The cell capture platform-cell sorter and CTC identification reagent were successfully developed. Medical rehabilitation platform-electronic moxibustion therapeutic apparatus, completed multi-center clinical trials and submitted to Anhui Provincial Food and Drug Administration for registration review. The science and technology projects in Anhui Province and Xuancheng City have passed the acceptance.
2020
high-tech enterprises Xuancheng Molecular Diagnostics High-end Medical Device Engineering Technology Research Center The revenue exceeds 20 million yuan, and it is included in the "industrial enterprises above designated size" Xuancheng's "Top Ten" Science and Technology Innovation Enterprises Immune POCT production line - fully automatic chemiluminescence immunoassay analyzer, passed the registration inspection. Immune POCT line-infection detection markers into production transformation. Core raw materials: Nano magnetic beads and colored microspheres were successfully developed and put into application Received the Announcement City 2020 Science and Technology Project. 6 new patents have been applied, including 3 invention patents.
2019
The project was approved by the high-level scientific and technological talent team of Anhui Province Won the key research and development project of Anhui Provincial Department of Science and Technology Announced city science and technology project project Immuno-POCT production line-automatic chemiluminescence instrument was successfully developed Diagnostic reagent GMP workshop was constructed and put into production Exosome purification reagent successfully developed 3 new patent applications
2018
Fully automatic nucleic acid extraction and purification instrument was approved for listing; won the "Zhong Nanshan Science and Technology Innovation Award" The first prototype of the fully automatic chemiluminescence instrument was successfully developed and entered into the functional test
2017
2017.9.29The company was established Complete plant construction within 2 months
Weizhenbio Bioengineering Technology Co., Ltd. founded in 2017, is a national-level high-tech enterprise focusing on the construction of immune and molecular POCT production lines. High-end medical device engineering technology research center.
